Rep. Murphy Calls CMS to Task for Proposal Limiting Mental Health Drug Access
Congressman Tim Murphy (R-PA) has written to the Centers for Medicare and Medicaid Services (CMS) asking the agency to justify its decision to strip key mental health drugs of their protected status in Medicare. Stating that “the CMS proposal appears not to be grounded in a concern over beneficiary health,” Murphy asked the agency to account for the rationale behind its controversial proposal issued earlier this month.
Read More on Rep. Murphy Calls CMS to Task for Proposal Limiting Mental Health Drug Access
CMS Proposes to Strip Mental Health Drugs of Protected Status in Part D
The Centers for Medicare and Medicaid Services (CMS) this week announced a proposed rule that would eliminate protected status for antidepressants and antipsychotics in Medicare Part D prescription drug plans.
The proposed rule, announced Monday, revises prior agency policy that required Part D plans to include on their formularies “all or substantially all” drugs within six classes: antidepressants, antipsychotics, anticonvulsants, antineoplastics, and immunosuppressants. This policy, known as the “six protected classes” policy, has been in effect since the inception of Part D and has enjoyed strong bipartisan support in Congress.
Read More on CMS Proposes to Strip Mental Health Drugs of Protected Status in Part D